598 related articles for article (PubMed ID: 21058631)
1. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
[TBL] [Abstract][Full Text] [Related]
2. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma.
Rocha CM; Carrola J; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Sep; 10(9):4314-24. PubMed ID: 21744875
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy.
Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Humpfer E; Spraul M; Carreira IM; Melo JB; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2010 Jan; 9(1):319-32. PubMed ID: 19908917
[TBL] [Abstract][Full Text] [Related]
4. 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma.
Zhou J; Xu B; Huang J; Jia X; Xue J; Shi X; Xiao L; Li W
Clin Chim Acta; 2009 Mar; 401(1-2):8-13. PubMed ID: 19056370
[TBL] [Abstract][Full Text] [Related]
5. RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.
Chen Y; Zhang R; Song Y; He J; Sun J; Bai J; An Z; Dong L; Zhan Q; Abliz Z
Analyst; 2009 Oct; 134(10):2003-11. PubMed ID: 19768207
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection diagnosis using metabonomics.
Godoy MM; Lopes EP; Silva RO; Hallwass F; Koury LC; Moura IM; Gonçalves SM; Simas AM
J Viral Hepat; 2010 Dec; 17(12):854-8. PubMed ID: 20070502
[TBL] [Abstract][Full Text] [Related]
7. ¹H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus.
Ouyang X; Dai Y; Wen JL; Wang LX
Lupus; 2011 Nov; 20(13):1411-20. PubMed ID: 21976403
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive urinary metabonomic diagnosis of human bladder cancer.
Pasikanti KK; Esuvaranathan K; Ho PC; Mahendran R; Kamaraj R; Wu QH; Chiong E; Chan EC
J Proteome Res; 2010 Jun; 9(6):2988-95. PubMed ID: 20337499
[TBL] [Abstract][Full Text] [Related]
9. Urinary metabonomic study on colorectal cancer.
Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
[TBL] [Abstract][Full Text] [Related]
10. Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution.
Napoli C; Sperandio N; Lawlor RT; Scarpa A; Molinari H; Assfalg M
J Proteome Res; 2012 Feb; 11(2):1274-83. PubMed ID: 22066465
[TBL] [Abstract][Full Text] [Related]
11. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
12. (1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool.
Zira AN; Theocharis SE; Mitropoulos D; Migdalis V; Mikros E
J Proteome Res; 2010 Aug; 9(8):4038-44. PubMed ID: 20527959
[TBL] [Abstract][Full Text] [Related]
13. Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics.
Psihogios NG; Gazi IF; Elisaf MS; Seferiadis KI; Bairaktari ET
NMR Biomed; 2008 Mar; 21(3):195-207. PubMed ID: 17474139
[TBL] [Abstract][Full Text] [Related]
14. [1H-MRS metabonomic analysis of plasma samples of esophageal cancer patients based on different pattern recognition].
Ayshamgul H; Batur M; Ilyar S
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):681-4. PubMed ID: 21122383
[TBL] [Abstract][Full Text] [Related]
15. Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints.
Teul J; Rupérez FJ; Garcia A; Vaysse J; Balayssac S; Gilard V; Malet-Martino M; Martin-Ventura JL; Blanco-Colio LM; Tuñón J; Egido J; Barbas C
J Proteome Res; 2009 Dec; 8(12):5580-9. PubMed ID: 19813770
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype.
Calvani R; Miccheli A; Capuani G; Tomassini Miccheli A; Puccetti C; Delfini M; Iaconelli A; Nanni G; Mingrone G
Int J Obes (Lond); 2010 Jun; 34(6):1095-8. PubMed ID: 20212498
[TBL] [Abstract][Full Text] [Related]
17. Revealing the metabonomic variation of EC using ¹H-NMR spectroscopy and its association with the clinicopathological characteristics.
Hasim A; Ma H; Mamtimin B; Abudula A; Niyaz M; Zhang LW; Anwer J; Sheyhidin I
Mol Biol Rep; 2012 Sep; 39(9):8955-64. PubMed ID: 22736106
[TBL] [Abstract][Full Text] [Related]
18. An insight into the metabolic responses of ultra-small superparamagnetic particles of iron oxide using metabonomic analysis of biofluids.
Feng J; Liu H; Zhang L; Bhakoo K; Lu L
Nanotechnology; 2010 Oct; 21(39):395101. PubMed ID: 20820093
[TBL] [Abstract][Full Text] [Related]
19. Metabolic profiling of glucuronides in human urine by LC-MS/MS and partial least-squares discriminant analysis for classification and prediction of gender.
Lutz U; Lutz RW; Lutz WK
Anal Chem; 2006 Jul; 78(13):4564-71. PubMed ID: 16808466
[TBL] [Abstract][Full Text] [Related]
20. Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis.
Li ZF; Wang J; Huang C; Zhang S; Yang J; Jiang A; Zhou R; Pan D
Rapid Commun Mass Spectrom; 2010 Sep; 24(18):2765-75. PubMed ID: 20814984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]